Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,629 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification and analysis of an early diagnostic marker for malignant melanoma: ZAR1 intra-genic differential methylation.
Shinojima Y, Terui T, Hara H, Kimura M, Igarashi J, Wang X, Kawashima H, Kobayashi Y, Muroi S, Hayakawa S, Esumi M, Fujiwara K, Ghosh S, Yamamoto T, Held W, Nagase H. Shinojima Y, et al. Among authors: kobayashi y. J Dermatol Sci. 2010 Aug;59(2):98-106. doi: 10.1016/j.jdermsci.2010.04.016. Epub 2010 May 20. J Dermatol Sci. 2010. PMID: 20654783 Free PMC article.
Identification of a novel E-box binding pyrrole-imidazole polyamide inhibiting MYC-driven cell proliferation.
Mishra R, Watanabe T, Kimura MT, Koshikawa N, Ikeda M, Uekusa S, Kawashima H, Wang X, Igarashi J, Choudhury D, Grandori C, Kemp CJ, Ohira M, Verma NK, Kobayashi Y, Takeuchi J, Koshinaga T, Nemoto N, Fukuda N, Soma M, Kusafuka T, Fujiwara K, Nagase H. Mishra R, et al. Among authors: kobayashi y. Cancer Sci. 2015 Apr;106(4):421-9. doi: 10.1111/cas.12610. Epub 2015 Mar 3. Cancer Sci. 2015. PMID: 25611295 Free PMC article.
Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy.
Takahashi H, Miura K, Nakagawa M, Sugitani M, Amano Y, Kurita D, Sakagami M, Ohtake S, Uchino Y, Kodaira H, Iriyama N, Kobayashi S, Hojo A, Kobayashi Y, Hirabayashi Y, Kusuda M, Hatta Y, Nakayama T, Takei M. Takahashi H, et al. Among authors: kobayashi y, kobayashi s. Leuk Lymphoma. 2016 Dec;57(12):2784-2790. doi: 10.3109/10428194.2016.1167205. Epub 2016 Apr 13. Leuk Lymphoma. 2016. PMID: 27071312
Copper deficiency anaemia.
Kobayashi Y, Hatta Y. Kobayashi Y, et al. Br J Haematol. 2014 Jan;164(2):161. doi: 10.1111/bjh.12577. Epub 2013 Oct 14. Br J Haematol. 2014. PMID: 24117099 Free article. No abstract available.
Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma.
Kurita D, Miura K, Nakagawa M, Ohtake S, Sakagami M, Uchino Y, Takahashi H, Kiso S, Hojo A, Kodaira H, Yagi M, Hirabayashi Y, Kobayashi Y, Iriyama N, Kobayashi S, Hatta Y, Kura Y, Sugitani M, Takei M. Kurita D, et al. Among authors: kobayashi y, kobayashi s. Int J Hematol. 2015 Jun;101(6):585-93. doi: 10.1007/s12185-015-1780-6. Epub 2015 Mar 17. Int J Hematol. 2015. PMID: 25776837
An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma.
Miura K, Takei K, Kobayashi S, Kiso S, Hirabayashi Y, Hojo A, Kodaira H, Yagi M, Kurita D, Kobayashi Y, Tanaka T, Iriyama N, Hatta Y, Kura Y, Yamazaki T, Sawada U, Takeuchi J. Miura K, et al. Among authors: kobayashi y, kobayashi s. Int J Hematol. 2011 Jul;94(1):90-96. doi: 10.1007/s12185-011-0884-x. Epub 2011 Jun 23. Int J Hematol. 2011. PMID: 21695600
Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy.
Miura K, Takahashi H, Nakagawa M, Izu A, Sugitani M, Kurita D, Sakagami M, Ohtake S, Uchino Y, Hojo A, Kodaira H, Yagi M, Kobayashi Y, Iriyama N, Kobayashi S, Kiso S, Hirabayashi Y, Hatta Y, Takei M. Miura K, et al. Among authors: kobayashi y, kobayashi s. Leuk Lymphoma. 2016;57(6):1335-41. doi: 10.3109/10428194.2015.1096352. Epub 2015 Oct 22. Leuk Lymphoma. 2016. PMID: 26390147
Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma.
Kobayashi Y, Hatta Y, Sugitani M, Hojo A, Nakagawa M, Kusuda M, Uchino Y, Takahashi H, Kiso S, Hirabayashi Y, Yagi M, Kodaira H, Kurita D, Miura K, Iriyama N, Kobayashi S, Kura Y, Horikoshi A, Sawada U, Takeuchi J, Takei M. Kobayashi Y, et al. Among authors: kobayashi s. Leuk Lymphoma. 2014 Nov;55(11):2514-9. doi: 10.3109/10428194.2014.889827. Epub 2014 Mar 17. Leuk Lymphoma. 2014. PMID: 24491027
10,629 results
You have reached the last available page of results. Please see the User Guide for more information.